Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study.
- DOI
- 10.1007/s13555-026-01897-6
- Published
- 2026 Sep 6
- Container
- Dermatology and therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-026-01897-6,
title = {Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study.},
author = {Huang Y and Pan T and Shi X and Zhang G and Cheng F and Geng S and Gu H and Li S and Diao Q and Wang X and Lu Y and Ji C and Li Y and Shi Y and Gu J and Chen L},
year = {2026},
journal = {Dermatology and therapy},
doi = {10.1007/s13555-026-01897-6},
url = {https://doi.org/10.1007/s13555-026-01897-6}
}RIS
TY - JOUR TI - Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study. AU - Huang Y AU - Pan T AU - Shi X AU - Zhang G AU - Cheng F AU - Geng S AU - Gu H AU - Li S AU - Diao Q AU - Wang X AU - Lu Y AU - Ji C AU - Li Y AU - Shi Y AU - Gu J AU - Chen L PY - 2026 JO - Dermatology and therapy DO - 10.1007/s13555-026-01897-6 UR - https://doi.org/10.1007/s13555-026-01897-6 ER -
APA
Y, H., T, P., X, S., G, Z., F, C., S, G., H, G., S, L., Q, D., X, W., Y, L., C, J., Y, L., Y, S., J, G., & L, C. (2026). Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01897-6
Source records
- pubmed · retrieved 2026-09-26T08:14:10.124Z